MX2022010391A - Metodo de preparacion de derivados de amina heterociclica. - Google Patents
Metodo de preparacion de derivados de amina heterociclica.Info
- Publication number
- MX2022010391A MX2022010391A MX2022010391A MX2022010391A MX2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A
- Authority
- MX
- Mexico
- Prior art keywords
- heterocyclicamine
- derivatives
- preparation
- present
- prepared
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000012535 impurity Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente divulgación se refiere a un método para preparar un derivado de amina heterocíclica, y el método de preparación según la presente divulgación tiene la ventaja de que puede prepararse un derivado de amina heterocíclica que tiene un contenido de impurezas reducido con un alto rendimiento.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200023899 | 2020-02-26 | ||
KR1020210025655A KR102531088B1 (ko) | 2020-02-26 | 2021-02-25 | 헤테로사이클릭아민 유도체의 제조 방법 |
PCT/KR2021/002440 WO2021172922A1 (ko) | 2020-02-26 | 2021-02-26 | 헤테로사이클릭아민 유도체의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022010391A true MX2022010391A (es) | 2022-09-05 |
Family
ID=77490106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022010391A MX2022010391A (es) | 2020-02-26 | 2021-02-26 | Metodo de preparacion de derivados de amina heterociclica. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230094404A1 (es) |
EP (1) | EP4112617A4 (es) |
JP (1) | JP7447291B2 (es) |
CN (1) | CN115151537B (es) |
BR (1) | BR112022016729A2 (es) |
CO (1) | CO2022011593A2 (es) |
JO (1) | JOP20220199A1 (es) |
MX (1) | MX2022010391A (es) |
WO (1) | WO2021172922A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102328682B1 (ko) | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1347971E (pt) | 2000-12-21 | 2006-06-30 | Bristol Myers Squibb Co | Inibidores tiazolilicos de tirosina-cinases da familia tec |
US20060030016A1 (en) | 2003-12-05 | 2006-02-09 | Graham Cheetham | Crystal structure of interleukin-2 tyrosine kinase (ITK) and binding pockets thereof |
WO2005066335A1 (en) | 2003-12-30 | 2005-07-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Crystal structure of the interleukin-2-inducible cell kinase (itk) kinase domain |
NZ575650A (en) | 2006-09-22 | 2011-10-28 | Pharmacyclics Inc | Pyrimidinopyrazole derivatives as inhibitors of Bruton's tyrosine kinase |
WO2012035055A1 (en) * | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
WO2014036016A1 (en) | 2012-08-31 | 2014-03-06 | Principia Biopharma Inc. | Benzimidazole derivatives as itk inhibitors |
CA2887465A1 (en) | 2012-10-04 | 2014-04-10 | University Of Utah Research Foundation | Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
AR098136A1 (es) | 2013-10-21 | 2016-05-04 | Merck Patent Gmbh | Compuestos de heteroarilo como inhibidores de btk y usos de los mismos |
CN104628657A (zh) * | 2013-11-06 | 2015-05-20 | 韩冰 | 一类治疗缺血性脑损伤的化合物及其用途 |
WO2016065138A1 (en) * | 2014-10-22 | 2016-04-28 | Dana-Farber Cancer Institute, Inc. | Thiazolyl-containing compounds for treating proliferative diseases |
KR102613433B1 (ko) * | 2017-10-11 | 2023-12-13 | 주식회사 대웅제약 | 신규한 페닐피리딘 유도체 및 이를 포함하는 약학 조성물 |
KR102328682B1 (ko) * | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 |
-
2021
- 2021-02-26 JP JP2022551582A patent/JP7447291B2/ja active Active
- 2021-02-26 US US17/799,774 patent/US20230094404A1/en active Pending
- 2021-02-26 BR BR112022016729A patent/BR112022016729A2/pt unknown
- 2021-02-26 CN CN202180015867.2A patent/CN115151537B/zh active Active
- 2021-02-26 EP EP21761001.3A patent/EP4112617A4/en active Pending
- 2021-02-26 MX MX2022010391A patent/MX2022010391A/es unknown
- 2021-02-26 JO JOP/2022/0199A patent/JOP20220199A1/ar unknown
- 2021-02-26 WO PCT/KR2021/002440 patent/WO2021172922A1/ko active Application Filing
-
2022
- 2022-08-17 CO CONC2022/0011593A patent/CO2022011593A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021172922A1 (ko) | 2021-09-02 |
JP2023515197A (ja) | 2023-04-12 |
EP4112617A4 (en) | 2024-03-13 |
JOP20220199A1 (ar) | 2023-01-30 |
CO2022011593A2 (es) | 2022-08-30 |
BR112022016729A2 (pt) | 2022-10-11 |
CN115151537B (zh) | 2024-09-06 |
CN115151537A (zh) | 2022-10-04 |
JP7447291B2 (ja) | 2024-03-11 |
US20230094404A1 (en) | 2023-03-30 |
EP4112617A1 (en) | 2023-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500093A1 (en) | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol | |
PH12019500493A1 (en) | Solvate form of (r)-2-amino-3-phenylpropyl carbamate | |
MY203897A (en) | Methods of producing omega-hydroxylated fatty acid derivatives | |
MY197904A (en) | Method for producing substituted 5-fluoro-1h-pyrazolopyridines | |
PH12019502865A1 (en) | Method for preparing intermediate of 4-methoxypyrrole derivative | |
MX395591B (es) | Metodo para preparar derivado de benzofurano | |
PH12019502638A1 (en) | Method for preparing intermediate of 4-methoxypyrrole derivative | |
MY178759A (en) | Method for preparing trichlorosilane | |
MY164371A (en) | Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase | |
MX2020006040A (es) | Intermedios para derivados de piperidina opticamente activos y procedimientos de preparacion de los mismos. | |
NZ749715A (en) | Leuconostoc mesenteroides cjlm119 strain producing reduced amount of gas, and kimchi production method using same | |
MX2022010391A (es) | Metodo de preparacion de derivados de amina heterociclica. | |
ZA202401405B (en) | Compositions and methods for anti-pacap antibodies | |
PH12022550095A1 (en) | Novel method for preparing long-acting drug conjugate through preparation of intermediate | |
MX2018009847A (es) | Metodo para preparar derivado de polietilenglicol-dialdehido. | |
IL279168B (en) | A process for the preparation of eribulin | |
EA200870320A1 (ru) | Способ получения г-ксф человека | |
WO2018196883A3 (zh) | 一种16β-甲基甾族化合物的制备方法 | |
WO2023108107A3 (en) | Modified immune cells and methods of using the same | |
ZA202202129B (en) | Process for the preparation of carboxylic acid derivatives of 3-bromo-4,5-dihydro-1h-pyrazoles | |
MX2022006383A (es) | Procedimiento de purificacion de la hormona foliculo-estimulante. | |
WO2016079757A3 (en) | NOVEL PROCESSES FOR THE PREPARATION OF SUBSTITUTED 5-HYDROXYMETHYL-OXAZOLIDINE-2-ONE | |
WO2016076573A3 (ko) | 블로난세린의 제조방법 및 그를 위한 중간체 | |
MX2025001080A (es) | Proceso para la preparacion de 2-cloro-3-fluoro-4-alcoxi-anilinas y 2-fluoro-3-clorofenol | |
MX2024007500A (es) | Procedimiento para la preparacion de derivados de (2r,3s)-2-(benzo[d]imidazolilpropil)piperidin-3-ol. |